Product
Neucardin
Aliases
Recombinant human Neuregulin-1 for Injection
1 clinical trial
1 indication
Indication
Chronic Systolic Heart FailureClinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Based on Standard Treatment to Evaluate the Effect of Injectable Neucardin on Cardiac Function and Reverse Ventricular Remodeling in Patients With Chronic Systolic Heart FailureStatus: Recruiting, Estimated PCD: 2024-06-01